Home › Funds › Aldebaran Capital, LLC › AVIR
Aldebaran Capital, LLC position in AVIR
ATEA PHARMACEUTICALS INC · Health Care
Aldebaran Capital, LLC reported holding 86,068 shares of AVIR (ATEA PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$448K, representing 0.32% of its reported portfolio and ranking #32 among its reported holdings. Aldebaran Capital, LLC has disclosed AVIR holdings in 5 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Aldebaran Capital, LLC's AVIR position evolved
Aldebaran Capital, LLC first disclosed a stake in AVIR in Q1 2025 at 37,500 shares (US$112K). The position peaked in Q1 2026 at 89,946 shares, worth US$484K. Across 5 filings, Aldebaran Capital, LLC increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 86,068 shares valued at US$448K — a reduction of -2,112 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 37.50K | $112.12K | New |
| Q4 2025 | 90.53K | $323.19K | New |
| Q1 2026 | 89.95K | $483.91K | Reduce |
| Q2 2026 | 88.18K | $410.04K | Reduce |
| Q3 2026 | 86.07K | $448.41K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AVIR and 13F data
AVIR (ATEA PHARMACEUTICALS INC) is a Health Care company. 30 other funds we track also report a position in AVIR — the largest reported positions include BML Capital Management, LLC (US$35.2M), TANG CAPITAL MANAGEMENT LLC (US$22.4M), Bain Capital Life Sciences Investors, LLC (US$9.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AVIR
- BML Capital Management, LLC 6.75M sh · $35.19M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 4.81M sh · $22.39M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 2.08M sh · $9.65M · Q2 2026
- Rosalind Advisors, Inc. 1.07M sh · $4.98M · Q2 2026
- Royal Palms Capital LLC 71.13K sh · $2.82M · Q3 2026
- CM Management, LLC 450.00K sh · $2.34M · Q3 2026
More on Aldebaran Capital, LLC
FAQ
How long has Aldebaran Capital, LLC held AVIR?
Aldebaran Capital, LLC has disclosed AVIR holdings in 5 of the last 7 reported quarters, going back to Q1 2025.
What is Aldebaran Capital, LLC's current position in AVIR?
As of Q3 2026, Aldebaran Capital, LLC holds 86.07K shares of AVIR (ATEA PHARMACEUTICALS INC), valued at $448.41K, representing 0.32% of its reported portfolio and ranking #32.
Has Aldebaran Capital, LLC been buying or selling AVIR?
In the latest 13F filing (Q3 2026), Aldebaran Capital, LLC reduced its position in AVIR. The position peaked in Q1 2026 at 89.95K shares.
Which other funds hold AVIR?
Other major institutional holders of AVIR include BML Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, Bain Capital Life Sciences Investors, LLC, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.